Premium
Misoprostol for postpartum hemorrhage: Moving from evidence to practice
Author(s) -
Starrs Ann,
Winikoff Beverly
Publication year - 2012
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2011.10.005
Subject(s) - misoprostol , medicine , clinical practice , intensive care medicine , maternal death , medical emergency , obstetrics , pregnancy , family medicine , population , environmental health , abortion , genetics , biology
Clinical and operational evidence indicates that misoprostol is a safe and effective technology for addressing postpartum hemorrhage, a major cause of maternal death. This research has not yet been translated into effective policies, programs, and practice in many parts of the world. Efforts to expand evidence‐based use of misoprostol are often complicated by misoprostol's range of indications, insufficient availability, a lack of evidence‐based guidelines and provider training, and misconceptions about the drug. The medical and health policy communities need to work together to translate research findings into changes in policy, knowledge, and clinical practice so that we can deliver on the world's promise to improve maternal health.